Wnt Signaling Pathway, a Potential Target for Alzheimer's Disease Treatment, is Activated by a Novel Multitarget Compound ASS234

Lignende værker

• Upregulation of Antioxidant Enzymes by ASS234, a Multitarget Directed Propargylamine for Alzheimer's Disease Therapy
  af: Ramos, Eva, et al.
  Udgivet: (2016)
• In silico assessment of the metabolism and its safety significance of multitarget propargylamine ASS234
  af: Ramos, Eva, et al.
  Udgivet: (2018)
• Highlights of ASS234: a novel and promising therapeutic agent for Alzheimer’s disease therapy
  af: Romero, Alejandro, et al.
  Udgivet: (2019)
• The proof-of-concept of ASS234: Peripherally administered ASS234 enters the central nervous system and reduces pathology in a male mouse model of Alzheimer disease
  af: Serrano, Mari Paz, et al.
  Udgivet: (2017)
• ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy
  af: Marco-Contelles, José, et al.
  Udgivet: (2016)